ExodusPoint Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-105,185
Closed -$4.87M 1633
2025
Q4
$4.87M Buy
105,185
+89,383
+566% +$3.74M 0.04% 479
2025
Q3
$553K Buy
+15,802
New +$549K 0.01% 1150
2025
Q2
Sell
-196,491
Closed -$5.87M 1537
2025
Q1
$5.87M Buy
196,491
+133,252
+211% +$4.07M 0.06% 364
2024
Q4
$1.81M Sell
63,239
-4,213
-6% -$139K 0.01% 750
2024
Q3
$2.61M Buy
+67,452
New +$2.41M 0.02% 631
2024
Q2
Sell
-88,603
Closed -$3.44M 1590
2024
Q1
$3.44M Buy
88,603
+50,351
+132% +$1.76M 0.03% 514
2023
Q4
$1.18M Buy
+38,252
New +$958K 0.01% 753
2023
Q3
Sell
-14,324
Closed -$308K 1759
2023
Q2
$308K Sell
14,324
-30,667
-68% -$696K ﹤0.01% 1532
2023
Q1
$1.08M Buy
+44,991
New +$1.19M 0.01% 1116
2022
Q3
Sell
-10,012
Closed -$177K 1932
2022
Q2
$177K Sell
10,012
-888
-8% -$14.9K ﹤0.01% 1679
2022
Q1
$222K Sell
10,900
-17,721
-62% -$335K ﹤0.01% 1869
2021
Q4
$535K Buy
+28,621
New +$558K 0.01% 1359
2021
Q1
Sell
-10,416
Closed -$209K 2168
2020
Q4
$209K Sell
10,416
-17,489
-63% -$341K ﹤0.01% 1708
2020
Q3
$581K Buy
+27,905
New +$504K 0.01% 936

Other funds holding COLL

ExodusPoint Capital Management's COLL Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 105,185 shares — an estimated $4.87M sold.

ExodusPoint Capital Management first reported a position in COLL in Q3 2020 and held it in 14 quarters. The position peaked at $5.87M in Q1 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • ExodusPoint Capital Management reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 105,185 Collegium Pharmaceutical shares in Q1 2026, an estimated $4.87M.
  • ExodusPoint Capital Management first reported a position in Collegium Pharmaceutical in Q3 2020 and held it in 14 quarters.
  • ExodusPoint Capital Management's Collegium Pharmaceutical position peaked at $5.87M in Q1 2025.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.